BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9207438)

  • 1. Prevention of thrombocytopenia by thrombopoietin in myelosuppressed rhesus monkeys accompanied by prominent erythropoietic stimulation and iron depletion.
    Neelis KJ; Qingliang L; Thomas GR; Cohen BL; Eaton DL; Wagemaker G
    Blood; 1997 Jul; 90(1):58-63. PubMed ID: 9207438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ; Hartong SC; Egeland T; Thomas GR; Eaton DL; Wagemaker G
    Blood; 1997 Oct; 90(7):2565-73. PubMed ID: 9326222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
    Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G
    Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high dose total-body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys.
    Neelis KJ; Dubbelman YD; Wognum AW; Thomas GR; Eaton DL; Egeland T; Wagemaker G
    Exp Hematol; 1997 Sep; 25(10):1094-103. PubMed ID: 9293907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of recombinant thrombopoietin in murine and nonhuman primate models for radiation-induced myelosuppression and stem cell transplantation.
    Wagemaker G; Neelis KJ; Hartong SC; Wognum AW; Thomas GR; Fielder PJ; Eaton DL
    Stem Cells; 1998; 16(6):375-86. PubMed ID: 9831863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-administration of Flt-3 ligand counteracts the actions of thrombopoietin in myelosuppressed rhesus monkeys.
    Hartong SC; Neelis KJ; Wagemaker G
    Br J Haematol; 2003 Apr; 121(2):359-67. PubMed ID: 12694260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of efficacy of thrombopoietin and granulocyte-macrophage colony-stimulating factor after total body irradiation and autologous bone marrow transplantation in Rhesus monkeys.
    Hartong SC; Neelis KJ; Visser TP; Wagemaker G
    Exp Hematol; 2000 Jul; 28(7):753-9. PubMed ID: 10907636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of recombinant TPO in murine And nonhuman primate models for myelosuppression and stem cell transplantation.
    Wagemaker G; Neelis KJ; Hartong SCC ; Wognum AW; Thomas GR; Fielder PJ; Eaton DL
    Stem Cells; 1998; 16 Suppl 2():127-41. PubMed ID: 11012185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single dose of thrombopoietin shortly after myelosuppressive total body irradiation prevents pancytopenia in mice by promoting short-term multilineage spleen-repopulating cells at the transient expense of bone marrow-repopulating cells.
    Neelis KJ; Visser TP; Dimjati W; Thomas GR; Fielder PJ; Bloedow D; Eaton DL; Wagemaker G
    Blood; 1998 Sep; 92(5):1586-97. PubMed ID: 9716586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of thrombopoietin and granulocyte colony-stimulating factor on neutrophil recovery in myelosuppressed mice.
    Grossmann A; Lenox J; Deisher TA; Ren HP; Humes JM; Kaushansky K; Sprugel KH
    Blood; 1996 Nov; 88(9):3363-70. PubMed ID: 8896401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.
    Grossmann A; Lenox J; Ren HP; Humes JM; Forstrom JW; Kaushansky K; Sprugel KH
    Exp Hematol; 1996 Aug; 24(10):1238-46. PubMed ID: 8765500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation.
    Mouthon MA; Van der Meeren A; Gaugler MH; Visser TP; Squiban C; Gourmelon P; Wagemaker G
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):867-75. PubMed ID: 10098443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice.
    Fibbe WE; Heemskerk DP; Laterveer L; Pruijt JF; Foster D; Kaushansky K; Willemze R
    Blood; 1995 Nov; 86(9):3308-13. PubMed ID: 7579432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue uptake of circulating thrombopoietin is increased in immune-mediated compared with irradiated thrombocytopenic mice.
    Chang M; Qian JX; Lee SM; Joubran J; Fernandez G; Nichols J; Knoppel A; Buzby JS
    Blood; 1999 Apr; 93(8):2515-24. PubMed ID: 10194430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further examination of various administration protocols of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia in myelosuppressed mice.
    Akahori H; Ozai M; Ida M; Shibuya K; Kato T; Miyazaki H
    Ther Apher; 1998 Feb; 2(1):58-64. PubMed ID: 10227790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression.
    Ohwada A; Rafii S; Moore MA; Crystal RG
    Blood; 1996 Aug; 88(3):778-84. PubMed ID: 8704230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promegapoietin-1a, an engineered chimeric IL-3 and Mpl-L receptor agonist, stimulates hematopoietic recovery in conventional and abbreviated schedules following radiation-induced myelosuppression in nonhuman primates.
    Farese AM; Smith WG; Giri JG; Siegel N; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(4):329-38. PubMed ID: 11463953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA; Marzec UM; Kelly AB; Cheung E; Tomer A; Nichol JL; Hanson SR; Stead RB
    Blood; 1997 Jan; 89(1):155-65. PubMed ID: 8978288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies.
    Murray NA; Watts TL; Roberts IA
    Pediatr Res; 1998 Jan; 43(1):148-51. PubMed ID: 9432127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets.
    Stoffel R; Wiestner A; Skoda RC
    Blood; 1996 Jan; 87(2):567-73. PubMed ID: 8555478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.